• Outstanding Seal
  • Antimicrobial properties
  • Promotes per-apical healing
  • Easy obturations and follow-up

BioRoot™ RCS. Succeed.

For more information on this exciting new product go to 


Article: Volume 42 Number 3 Page 250 - April 2015

Prev    Article P250    Next  Read article

  Dent Update 2015; 42: 250-260

Oral medicine:  Mouth Cancer for Clinicians Part 1: Cancer

Feedback:  0 comments, 0 ratings


Abstract: A MEDLINE search early in 2015 revealed more than 250,000 papers on head and neck cancer; over 100,000 on oral cancer; and over 60,000 on mouth cancer. Not all publications contain robust evidence. We endeavour to encapsulate the most important of the latest information and advances now employed in practice, in a form comprehensible to healthcare workers, patients and their carers. This series offers the primary care dental team, in particular, an overview of the aetiopathogenesis, prevention, diagnosis and multidisciplinary care of mouth cancer, the functional and psychosocial implications, and minimization of the impact on the quality of life of patient and family.

Clinical relevance: This article offers the dental team a simplified overview of carcinogenesis, and a review of cancers that affect the oral region.

Author notes: Nicholas Kalavrezos, FRCS, FFD RCSI, MD, Maxillofacial and Reconstructive Surgeon of The Head, Face and Neck, University College London Hospital and The Harley Street Clinic. Assistant Secretary, European Association of Cranio-Maxillofacial Surgery and Professor Crispian Scully, CBE, FMedSci, DSc, FDS, MD, Co-Director, WHO Centre on Oral Health and General Health; Professor Emeritus, UCL, London; King James IV Professor, Royal College of Surgeons of Edinburgh.

Objective: To provide the dental team with a simplified overview of carcinogenesis and a review of cancers that affect the oral region.